Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:19 PM
Ignite Modification Date:
2025-12-24 @ 7:19 PM
NCT ID:
NCT01039103
Eligibility Criteria:
INCLUSION criteria
* Diagnosis of RRMS (per McDonald criteria, 2005) with dissemination in time and space OR a diagnosis of CIS confirmed by MRI. Patients with CIS who only have optic neuritis will be excluded from this study
* A maximum Expanded Disability Status Scale (EDSS) score of ≤ 6
* New neurological symptoms or exacerbation of prior neurological symptoms of over 24 hours duration but \<7 days duration, verified by neurological examination
EXCLUSION criteria:
* Primary progressive MS.
* Secondary progressive MS without superimposed relapses.
* Received systemic corticosteroids within 4 weeks of screening for treatment of MS or other conditions.
* any contraindication for treatment with (systemic) corticosteroids
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT01039103
Study Brief:
Protocol Section:
NCT01039103